Catalyst Wire Dossier Catalyst Wire Dossier

Sevikar

· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sevikar, covering 2018-12-24 to 2018-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure [Phase 4]

See pricing